Epidiolex sales, potential CBD treatment for PTSD and more: GW Pharma CEO



GW Pharmaceutical CEO Justin Gover tells “Mad Money” host Jim Cramer the company sold $300 million worth of its CBD-based epilepsy drug in 2019 and …

3 Comments

Leave a Reply

Your email address will not be published.


*